Pylopass®
Product description
» Proprietary strain: Pylopass® is a Lactobacillus reuteri DSMZ 17648, which
specifically binds and coaggregates with H. pylori to reduce the bacterial load.
» Efficiency: Pylopass® decrease the risk of developing gastritis and peptic ulcer disease and can increase the efficacy of Antibiotics treatment. » No side effects: Pylopass® does not alter the microflora of the gut and does not contribute to the antibiotic resistance.
Reduction of H. pylori load in 60% of the subjects in only 2 weeks
Patented Mechanism of Action: Pylopass® is able to recognize surface structures on H. pylori and to form coaggregates. Those Co-aggregates are eliminated from the organism through the gastrointestinal tract. This leads to a reduction of Helicobacter pylori load in the stomach.
Read more
» Efficiency: Pylopass® decrease the risk of developing gastritis and peptic ulcer disease and can increase the efficacy of Antibiotics treatment. » No side effects: Pylopass® does not alter the microflora of the gut and does not contribute to the antibiotic resistance.
Reduction of H. pylori load in 60% of the subjects in only 2 weeks
Patented Mechanism of Action: Pylopass® is able to recognize surface structures on H. pylori and to form coaggregates. Those Co-aggregates are eliminated from the organism through the gastrointestinal tract. This leads to a reduction of Helicobacter pylori load in the stomach.
Specifications
Categories | Food Supplements / Nutraceuticals |
---|---|
Supplied from | Spain |
Product Certifications | Sustainable Seafood |
Products from other suppliers
❮
❯
-
geniVida®
-
EXCELSPONGE
-
Solanic® 200 & 300
-
Maize grits for extrusion of snacks
-
Buffered lactic acid
-
NEW: PROFERTIL® inositol – fertility easy-to-go for PCOS patients
-
OVOMET
-
Galimax Flavor K-10
-
ChanaTein™ Chickpea Protein Concentrate
-
SALTWELL® Natural. Sea salt with 35% less sodium & no anticaking additives
Pylopass®